Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer

This study has been terminated.
(Sponsor proceeded with a phase III study for same indication.)
Information provided by (Responsible Party):
NewLink Genetics Corporation Identifier:
First received: January 31, 2008
Last updated: May 29, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2014
  Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 28, 2014